LATEST NEWS

New gene therapies, deeper insights into stem cells, and advances in imaging and artificial intelligence are making researchers, physicians, and some patients optimistic about retinal disease treatment. 
Safety concerns include liver injury and interactions with other drugs
No tobacco product is safe, says the lung heath group
Discovery seen as possibly leading to new anti-TB drugs
Study points to permanent hair dye and straighteners
How malaria parasites evade first-line drugs
A new way to fight staph infections
Score could help prevent misuse among cancer patients
'All head impacts are not the same'

P&T November 2019
Table of Contents

Features

Two decades after the landmark To Err Is Human report was published, patient safety has improved but medication errors remain a significant problem.

Amantadine had the highest response rate as an awakening agent among TBI patients in the ICU in this retrospective chart review study.

Shouldn’t engaging physicians in formulary decisions improve formulary adherence? This study at an academic medical center found otherwise.

Health Care & Law

Digital health products are coming on strong, and P&T committees and health care professionals will have to manage their use.

Departments

Prescription: Washington

CMS proposes new standard electronic prior authorization.

Medication Errors

Workarounds may get the job done but may let long-term problems fester.

Industry announcements